Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1991 2
1993 4
1995 3
1996 3
1998 1
1999 2
2001 1
2002 1
2003 1
2004 1
2005 3
2006 1
2007 1
2008 2
2009 4
2010 1
2011 1
2012 2
2013 5
2014 2
2015 3
2016 5
2017 4
2018 4
2019 4
2020 10
2021 8
2022 5
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Apixaban versus warfarin in patients with atrial fibrillation.
Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators. Granger CB, et al. N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27. N Engl J Med. 2011. PMID: 21870978 Free article. Clinical Trial.
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
Hokusai-VTE Investigators; Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob GE, Schellong SM, Schwocho L, Segers A, Shi M, Verhamme P, Wells P. Hokusai-VTE Investigators, et al. N Engl J Med. 2013 Oct 10;369(15):1406-15. doi: 10.1056/NEJMoa1306638. Epub 2013 Aug 31. N Engl J Med. 2013. PMID: 23991658 Free article. Clinical Trial.
Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial.
White RJ, Jerjes-Sanchez C, Bohns Meyer GM, Pulido T, Sepulveda P, Wang KY, Grünig E, Hiremath S, Yu Z, Gangcheng Z, Yip WLJ, Zhang S, Khan A, Deng CQ, Grover R, Tapson VF; FREEDOM-EV Investigators. White RJ, et al. Among authors: jerjes sanchez c. Am J Respir Crit Care Med. 2020 Mar 15;201(6):707-717. doi: 10.1164/rccm.201908-1640OC. Am J Respir Crit Care Med. 2020. PMID: 31765604 Free PMC article. Clinical Trial.
Severe COVID-19 disease and thromboinflammation.
Jerjes-Sánchez C. Jerjes-Sánchez C. Arch Cardiol Mex. 2020;90(3):257-258. doi: 10.24875/ACM.M20000075. Arch Cardiol Mex. 2020. PMID: 32952161 Free article. English. No abstract available.
Riociguat in the Treatment of Pulmonary Arterial Hypertension.
Jerjes-Sánchez C, Glenn-Valdez H, Zayas N, Cueto-Robledo G, Bonola L, Pech-Alonso B, Ramírez A, Flores-Puente F, García-Aguilar H, Espitia-Hernández G, Montes GP, Pulido T. Jerjes-Sánchez C, et al. Arch Med Res. 2022 Jun;53(4):352-358. doi: 10.1016/j.arcmed.2022.04.001. Epub 2022 Apr 27. Arch Med Res. 2022. PMID: 35487793 Review.
Therapeutic Applications of Cannabinoids in Cardiomyopathy and Heart Failure.
Garza-Cervantes JA, Ramos-González M, Lozano O, Jerjes-Sánchez C, García-Rivas G. Garza-Cervantes JA, et al. Among authors: jerjes sanchez c. Oxid Med Cell Longev. 2020 Oct 27;2020:4587024. doi: 10.1155/2020/4587024. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 33194003 Free PMC article. Review.
Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE.
Jerjes-Sánchez C, Rodriguez D, Farjat AE, Kayani G, MacCallum P, Lopes RD, Turpie AGG, Weitz JI, Haas S, Ageno W, Goto S, Goldhaber SZ, Angchaisuksiri P, Nielsen JD, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE investigators. Jerjes-Sánchez C, et al. TH Open. 2021 Jan 27;5(1):e24-e34. doi: 10.1055/s-0040-1722611. eCollection 2021 Jan. TH Open. 2021. PMID: 33532693 Free PMC article.
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Ghofrani HA, Simonneau G, D'Armini AM, Fedullo P, Howard LS, Jaïs X, Jenkins DP, Jing ZC, Madani MM, Martin N, Mayer E, Papadakis K, Richard D, Kim NH; MERIT study investigators. Ghofrani HA, et al. Lancet Respir Med. 2024 Apr;12(4):e21-e30. doi: 10.1016/S2213-2600(24)00027-4. Lancet Respir Med. 2024. PMID: 38548406 Clinical Trial.
84 results